International World Cancer Day 2014 – Ford Donates $400 000
GM FOUNDATION DONATES $400,000 TO KARMANOS CANCER INSTITUTE
DETROIT – The General Motors Foundation is donating $400,000 to support cancer research conducted by the Barbara Ann Karmanos Cancer Institute. The grant celebrates Karmanos’ 32nd Annual Dinner and brings to nearly $7.3 million the combined contributions from the GM Foundation and GM over the last 17 years.
“Our donation to Karmanos Cancer Institute is part of the GM Foundation’s larger commitment to support the research and prevention of the major illnesses of heart disease, cancer and diabetes,” said GM Foundation President Vivian Pickard. “Due to the tireless efforts of the Karmanos team and their excellent reputation, we are again extending our support to continue the fight against cancer.”
GM President Dan Ammann and his wife, Pernilla, chief operating officer of Mother New York, will serve as chairs for the Annual Dinner on Saturday, April 26, at the Fox Theatre. This is the fourth consecutive year that a member of GM senior leadership has chaired the event.
“Pernilla and I are humbled by the opportunity to continue GM’s commitment to Karmanos, and act as champions for such an important cause,” Ammann said.
Cadillac is the Host Sponsor of this year’s Annual Dinner. Proceeds from the event will fund the renovation of the Institute’s infusion center, where chemotherapy, a significant component of treatment for many cancer patients, is administered. The renovations will enhance the patients’ experience, providing a more comfortable and soothing environment as they receive critical care.
“We are extremely grateful for the outstanding support of General Motors and the GM Foundation,” said Gerold Bepler, M.D., Ph.D., president and CEO, Barbara Ann Karmanos Cancer Institute. “The GM Foundation has consistently supported our innovative cancer research, which is critical for the advancements of new treatment discoveries. In addition, the tremendous contributions from GM over the span of several years demonstrates the company’s steadfast commitment to cancer patients and the health and well-being of those in our community.”